Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics

Arnaud is the Director of Process Development at Triumvira. He’s responsible for the MSAT group, ranging from Process Development and Automation, for both Autologous and Allogeneic products, as well as the analytical needs for our clinical trials and external manufacturing. Prior to Triumvira, he was working at a CGT CDMO called C3i Center, based in Montreal. There he was managing the operations of the GMP MFG unit where most projects were CAR and TCR based products (with the occasional stem cell or TIL project). He has a scientific background, with a PhD in Cell and Molecular Biology from the University of Cambridge in the UK.

Also Speaking

Scott Bertch

Executive Director, Clinical Site Head • Tenaya Therapeutics

Tony Ward

Chief Technology Officer • Curate Biosciences

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Event Info


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.